Evidence supporting the use of: Resveratrol
For the health condition: Conjunctivitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol has been studied for its potential anti-inflammatory and antioxidant properties, which may be relevant to the treatment or support of conjunctivitis (inflammation of the conjunctiva). Preclinical research, including in vitro and animal studies, suggests that resveratrol can inhibit the production of pro-inflammatory cytokines and reduce oxidative stress in ocular tissues. For example, studies in animal models of allergic conjunctivitis have demonstrated that topical or systemic application of resveratrol can reduce clinical signs of inflammation, including redness, swelling, and infiltration of inflammatory cells. Mechanistically, resveratrol appears to modulate pathways such as NF-κB and may downregulate the expression of inflammatory mediators like TNF-α, IL-6, and histamine. However, while these results are promising, the evidence is currently limited to laboratory and animal studies. There are no robust clinical trials in humans that directly evaluate the efficacy or safety of resveratrol for the treatment or prevention of conjunctivitis. As such, while there is a scientific rationale and some experimental data supporting its use, the overall strength of evidence is weak (rated 2 out of 5), and resveratrol should not be considered a proven or standard treatment for conjunctivitis. Further research, especially well-designed human clinical trials, is required to establish its efficacy and safety in this context.

More about resveratrol
More about Conjunctivitis